SNS Financial Group’s St Jude Medical STJ Stock Holding History

SNS Financial Group’s Portfolio STJ Stock Details STJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-12,600	Closed	-$1.01M	–	264
2016 Q4	$1.01M	Buy	12,600 +8,600	+215%	+$683K	0.3%	70
2016 Q3	$319K	Hold	4,000	–	–	0.09%	102
2016 Q2	$312K	Sell	4,000 -200	-5%	-$14.3K	0.08%	103
2016 Q1	$231K	Hold	4,200	–	–	0.06%	103
2015 Q4	$259K	Buy	+4,200	New	+$265K	0.06%	96
2015 Q3	–	Sell	-3,000	Closed	-$219K	–	138
2015 Q2	$219K	Buy	+3,000	New	+$217K	0.07%	109

Other funds holding STJ

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

JWA

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

SNS Financial Group's STJ Position: Q1 2017 in Review

SNS Financial Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 12,600 shares — an estimated $1.01M sold.

SNS Financial Group first reported a position in STJ in Q2 2015 and held it in 6 quarters. The position peaked at $1.01M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

SNS Financial Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
SNS Financial Group sold 12,600 St Jude Medical shares in Q1 2017, an estimated $1.01M.
SNS Financial Group first reported a position in St Jude Medical in Q2 2015 and held it in 6 quarters.
SNS Financial Group's St Jude Medical position peaked at $1.01M in Q4 2016.
4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on SNS Financial Group's 13F filing for Q1 2017, filed 12 May 2017.